ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 22, 2012
Dividend Growth Gem Medtronic Posts a Decent First Quarter
Medical heart-rhythm device maker Medtronic posted solid first-quarter results. The company remains an attractive dividend growth idea.
Aug 21, 2012
Best Idea Altria Raises Guidance
Results of a debt tender offer were lower than expected, leading the firm to upwardly revise earnings estimates.
Aug 21, 2012
Best Buy on Its Way to Becoming a Value Stock
Best Buy continues to struggle, but we think it will become a value stock--just not yet.
Aug 21, 2012
Is Growth Back at Urban Outfitters?
We dig into the retailer's strong second quarter, but we're not fans of shares here.
Aug 21, 2012
Footlocker Rides Nike to Strong Second Quarter Results
Footlocker continues to capitalize on Nike's strong product offerings, but we think shares are fairly valued.
Aug 20, 2012
Lowe’s Second Quarter Disappoints; Outlook Slashed
Home improvement heavyweight Lowe's reported a poor second quarter, substantially lagging Home Depot. We continue to stay away from the shares.
Aug 20, 2012
Aetna Nabs Coventry
Consolidation continues in the health insurer space, as Aetna acquires Coventry, a company leveraged to Medicaid.
Aug 17, 2012
The Gap is Back…But We’re Not Chasing It Here
Gap continues to post excellent results, but we think the stock price is now way ahead of its fundamentals.
Aug 17, 2012
Is Sears the Ultimate Value Stock?
We don't think so, but we assess the retailer after its weak second quarter results and bullish commentary from Bruce Berkowitz.
Aug 17, 2012
Wal-Mart Keeps Rolling
After struggling in 2010, Wal-Mart is back on track. Still, we think shares are fairly valued.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.